phase readout
saveNCT05006794: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Solid Malignancies
view source ↗
comments(0)
5-min edit window · permanent after that